Drawing for JAZALYSTO

USPTO serial 79300623

JAZALYSTO

Reviewed by CopyMark Law Group

Status 402
Filing date
Status date
Registration date
Examiner
Law office
INITIAL REVIEW/SERIALIZATION BRANCH(MAILROOM)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with JAZALYSTO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccinesSECTION 70 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 14, 2021DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Mar 13, 2021DETHDEATH OF INTERNATIONAL REGISTRATION
Jan 15, 2021MAFRAPPLICATION FILING RECEIPT MAILED
Jan 11, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 7, 2021LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED
Dec 24, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance